Patents Assigned to Board of Regents for the University of Oklahoma
  • Patent number: 9359196
    Abstract: Antiproliferative compositions that include CLEFMA, as well as liposomal compositions containing said antiproliferative compositions, are disclosed. Also disclosed are methods of making and using the antiproliferative compositions and liposomal compositions.
    Type: Grant
    Filed: October 24, 2011
    Date of Patent: June 7, 2016
    Assignee: The Board of Regents of the University of Oklahoma
    Inventors: Vibhudutta Awasthi, Pallavi Lagisetty, Hrushikesh Agashe
  • Patent number: 9361877
    Abstract: An ultrasonic communication system comprising an enclosure, a first module and a second module is described. The enclosure has an internal surface, an external surface, and defines at least one metal channel. The first module comprises an ultrasonic transceiver disposed within the enclosure. The first module is positioned on the internal surface of the enclosure and is capable of transmitting and/or receiving modulated ultrasonic waves via the metal channel. The second module is positioned on the external surface of the enclosure and is adapted to transmit and/or receive modulated ultrasonic waves from the first module via the metal channel.
    Type: Grant
    Filed: October 30, 2012
    Date of Patent: June 7, 2016
    Assignee: The Board of Regents of the University of Oklahoma
    Inventors: John K. Antonio, Mark B. Yeary, Thomas D. Hosman
  • Patent number: 9337617
    Abstract: A tunable semiconductor laser having, in one embodiment, a higher bias voltage end, a lower bias voltage end, and an optically active gain region comprising a band-gap configured to emit light at an emission wavelength that is tunable when an electric field is generated across the optically active gain region by applying a bias voltage thereto, an electron quantum well (QW) layer positioned closer to the higher bias voltage end than the lower voltage bias end, and a hole QW layer positioned closer to the lower bias voltage end than the higher bias voltage end and comprising a type-II band alignment with the electron QW layer such that the band-gap is determined by an energy difference between a ground electron state in the electron QW layer and a ground hole state in the hole QW layer, wherein the emission wavelength is redshifted upon an increase in a bias voltage applied to the optically active gain region.
    Type: Grant
    Filed: February 24, 2015
    Date of Patent: May 10, 2016
    Assignee: The Board of Regents of the University of Oklahoma
    Inventors: Rui Q. Yang, Zhaobing Tian, Lu Li, Michael B. Santos, Matthew B. Johnson, Yuchao Jiang
  • Patent number: 9303087
    Abstract: Monoclonal antibodies against LRP6 and that block the Wnt signaling pathway are disclosed. Methods of production and use thereof are also disclosed.
    Type: Grant
    Filed: June 9, 2014
    Date of Patent: April 5, 2016
    Assignee: The Board of Regents of the University of Oklahoma
    Inventors: Jian-xing Ma, Kyungwon Lee, Ying Chen
  • Patent number: 9287683
    Abstract: A semiconductor interband laser that includes a first cladding layer formed using a first high-doped semiconductor material having a first refractive index/permittivity and a second cladding layer formed using a second high-doped semiconductor material having a second refractive index/permittivity. The laser also includes a waveguide core having a waveguide core refractive index/permittivity, the waveguide core is positioned between the first and the second cladding layers. The waveguide core including an active region adapted to generate light based on interband transitions. The light being generated defines the lasing wavelength or the lasing frequency. The first refractive index and the second refractive index are lower than the waveguide core refractive index. The first cladding layer and/or the second cladding layers can also be formed using a metal.
    Type: Grant
    Filed: December 16, 2014
    Date of Patent: March 15, 2016
    Assignee: The Board of Regents of the University of Oklahoma
    Inventors: Rui Q. Yang, Tetsuya Mishima, Michael B. Santos, Zhaobing Tian, Matthew B. Johnson, Robert T. Hinkey
  • Publication number: 20160060315
    Abstract: Peptide compounds based on the CAP37 protein are disclosed, along with methods for treating various infections, wounds, and conditions, and methods of promoting healing and acceptance of grafts, using compositions containing these peptide compounds.
    Type: Application
    Filed: April 16, 2014
    Publication date: March 3, 2016
    Applicant: The Board of Regents of the University of Oklahoma
    Inventors: Heloise Anne Pereira, Ann KASUS-JACOBI, Gina L. GRIFFITH
  • Patent number: 9273334
    Abstract: The presently disclosed inventive concepts are directed in certain embodiments to a method of producing protoporphyrin IX by (1) cultivating a strain of Shewanella bacteria in a culture medium under conditions suitable for growth thereof, and (2) recovering the protoporphyrin IX from the culture medium. The strain of Shewanella bacteria comprises at least one mutant hemH gene which is incapable of normal expression, thereby causing an accumulation of protoporphyrin IX. In certain embodiments of the method, the strain of Shewanella bacteria is a strain of S. loihica, and more specifically may be S. loihica PV-4. In certain embodiments, the mutant hemH gene of the strain of Shewanella bacteria may be a mutant of shew_2229 and/or of shew_1140.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: March 1, 2016
    Assignee: The Board of Regents of the University of Oklahoma
    Inventors: Jizhong Zhou, Dongru Qiu, Zhili He, Ming Xie
  • Publication number: 20160047792
    Abstract: System and method relates to measuring separation rate of water from water-in-crude oil emulsions at elevated temperature. The system includes an electrolytic interface (conductivity) cell comprising a plurality of capacitance/conductance probes disposed at different heights in a fluid stream disposed within the interface cell and an analyzer. Logic of the analyzer determines the separation rate based on signals received from the plurality of capacitance/conductance probes in the interface cell that are coupled to monitor the fluid stream. Methods for making and using the system are also disclosed.
    Type: Application
    Filed: July 17, 2015
    Publication date: February 18, 2016
    Applicants: Phillips 66 Company, Board of Regents of the University of Oklahoma
    Inventors: Moniraj GHOSH, Brian P. GRADY, Jeffrey H. HARWELL, James A. MILES
  • Patent number: 9246680
    Abstract: Systems and methods for encoding a message are disclosed. A message may be passed from a first node to a second node via a communication link using a multi-stage cryptography algorithm distributed between the first node and the second node and applied by circuitry within the first node and the second node in which the multi-stage cryptography algorithm includes instructions for transmitting at least two optical signal transmissions across the communication path and using a number of independent transformations of polarization state of the optical signal transmission by a combination of the first node and the second node at least equal to the number of optical signal transmissions across the communication link.
    Type: Grant
    Filed: July 11, 2014
    Date of Patent: January 26, 2016
    Assignee: The Board of Regents of the University of Oklahoma
    Inventors: Pramode Verma, Mayssaa El Rifai, Nikhil Vishnu Punekar
  • Publication number: 20160000893
    Abstract: A set of target peptides are presented by HLA A*0201 on the surface of ovarian cancer cells. They are envisioned to among other things (a) stimulate an immune response to the proliferative disease, e.g., ovarian cancer, (b) function as immunotherapeutics in adoptive T-cell therapy or as a vaccine, (c) facilitate antibody recognition of tumor boundaries in surgical pathology samples, (d) act as biomarkers for early detection and/or diagnosis of the disease, and (e) act as targets in the generation antibody-like molecules which recognize the target-peptide/MHC complex.
    Type: Application
    Filed: December 13, 2013
    Publication date: January 7, 2016
    Applicants: UNIVERSITY OF VIRGINIA PATENT FOUNDATION, THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA
    Inventors: Donald F. Hunt, Jeffrey Shabanowitz, Jennifer G. Abelin, William H. Hildebrand
  • Patent number: 9228001
    Abstract: Mutants of cholesterol-dependent cytolysins comprising at least one amino acid substitution in at least one of Loop 1, Loop 2, or Loop 3 of Domain 4, nucleic acids, vectors, and host cells encoding such polypeptide mutants, and compositions and vaccines comprising such polypeptide mutants.
    Type: Grant
    Filed: February 21, 2012
    Date of Patent: January 5, 2016
    Assignee: The Board of Regents of the University of Oklahoma
    Inventor: Rodney K. Tweten
  • Publication number: 20150374995
    Abstract: The present invention relates in general to methodologies for the treatment quenching preconditioning and communication between the intrinsic cardiac nervous system and an electrical stimulus. In particular, the present invention utilizes spinal cord stimulation to alter and/or affect the intrinsic cardiac nervous system and thereby protect the myocytes, stabilize myocardial electrical instability and/or alleviate or diminish cardiac pathologies.
    Type: Application
    Filed: July 6, 2015
    Publication date: December 31, 2015
    Applicant: The Board of Regents of the University of Oklahoma
    Inventors: Robert D. Foreman, Jeffrey L. Ardell, John A. Armour, Michael J.L. DeJongste, Bengt G.S. Linderoth
  • Publication number: 20150374785
    Abstract: Peptide compounds based on the CAP37 protein are disclosed, along with methods for treating various infections, wounds, and conditions, and methods of promoting healing and acceptance of grafts, using compositions containing these peptides.
    Type: Application
    Filed: December 3, 2013
    Publication date: December 31, 2015
    Applicant: The Board of Regents of the University of Oklahoma
    Inventors: Heloise Anne Pereira, Anne Kasus-Jacobi, Gina L. Griffith
  • Patent number: 9200024
    Abstract: A methodology for polymer grafting by a polysaccharide synthase allows the creation of a variety of glycosaminoglycan oligosaccharides that have a natural, chimeric, hybrid and/or unnatural sugar structure and/or a targeted size (i.e., substantially monodisperse in size).
    Type: Grant
    Filed: December 14, 2011
    Date of Patent: December 1, 2015
    Assignee: The Board of Regents of the University of Oklahoma
    Inventors: Paul L. DeAngelis, Alison Sismey-Ragatz
  • Patent number: 9173839
    Abstract: Anionic non-phospholipids, as well as lipid nanostructures formed therefrom, are disclosed herein. Also disclosed are methods of producing and using same.
    Type: Grant
    Filed: April 15, 2013
    Date of Patent: November 3, 2015
    Assignee: The Board of Regents of the University of Oklahoma
    Inventors: Vibhudutta Awasthi, Pallavi Lagisetty
  • Patent number: 9166084
    Abstract: A photovoltaic (PV) device, comprising a PV interband cascade (IC) stage, wherein the IC PV stage comprises an absorption region with a band gap, the absorption region configured to absorb photons, an intraband transport region configured to act as a hole barrier, and an interband tunneling region configured to act as an electron barrier. An IC PV architecture for a photovoltaic device, the IC PV architecture comprising an absorption region, an intraband transport region coupled to the absorption region, and an interband tunneling region coupled to the intraband transport region and to the adjacent absorption region, wherein the absorption region, the intraband transport region, and the interband tunneling region are positioned such that electrons will flow from the absorption region to the intraband transport region to the interband tunneling region.
    Type: Grant
    Filed: February 9, 2011
    Date of Patent: October 20, 2015
    Assignee: Board of Regents University of Oklahoma
    Inventors: Rui Q. Yang, Zhaobing Tian, Tetsuya D. Mishima, Michael B. Santos, Matthew B. Johnson, John F. Klem
  • Patent number: 9139780
    Abstract: The present invention provides methods for stimulating or enhancing the conversion of coal to methane. The methods of the current invention subject coal to an oxidation step, for example ozonolysis, thereby converting at least a portion of the coal to partially-oxidized and water-soluble forms of organic matter. Subsequent contact of the oxidized coal components with a suitable inoculum containing a methanogenic microbial community produces methane.
    Type: Grant
    Filed: April 9, 2012
    Date of Patent: September 22, 2015
    Assignee: The Board of Regents of The University of Oklahoma
    Inventors: Joseph Suflita, Mark Nanny, Margarita Mendivelso Castro, Jan Sunner
  • Patent number: 9110080
    Abstract: The present invention relates generally to a methodology for assaying the binding of a peptide to an individual, specific, soluble HLA molecule using fluorescence polarization. The peptides utilized in the method may be identified by indirect methods utilizing T lymphocytes, or by a direct method of epitope discovery described herein.
    Type: Grant
    Filed: May 26, 2011
    Date of Patent: August 18, 2015
    Assignee: The Board of Regents of the University of Oklahoma
    Inventors: William H. Hildebrand, Rico Buchli
  • Patent number: 9096679
    Abstract: Peptide compounds based on the CAP37 (cationic antimicrobial protein of Mr 37 kDa) protein are disclosed, along with methods for treating various infections, wounds, and conditions, and methods of promoting healing and acceptance of grafts, using compositions containing these peptides.
    Type: Grant
    Filed: December 3, 2013
    Date of Patent: August 4, 2015
    Assignee: The Board of Regents of the University of Oklahoma
    Inventor: Heloise Anne Pereira
  • Patent number: 9072901
    Abstract: The present invention relates in general to methodologies for the treatment quenching preconditioning and communication between the intrinsic cardiac nervous system and an electrical stimulus. In particular, the present invention utilizes spinal cord stimulation to alter and/or affect the intrinsic cardiac nervous system and thereby protect the myocytes, stabilize myocardial electrical instability and/or alleviate or diminish cardiac pathologies.
    Type: Grant
    Filed: November 23, 2010
    Date of Patent: July 7, 2015
    Assignee: The Board of Regents of the University of Oklahoma
    Inventors: Robert D. Foreman, Jeffrey L. Ardell, John A. Armour, Michael J. L. DeJongste, Bengt G. S. Linderoth